123 filings
Page 5 of 7
8-K
0za75ihkvl
1 Mar 19
Wave Life Sciences Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Business Update
7:38am
8-K
efyh d64pj
24 Jan 19
Wave Life Sciences Prices $150 Million Public Offering of Ordinary Shares
4:34pm
8-K
7gs8dp7m
23 Jan 19
Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares
5:09pm
8-K
1buappuvzj
3 Jan 19
Regulation FD Disclosure
8:24am
8-K
cz9g tc98odvqya185
6 Dec 18
Regulation FD Disclosure
7:39am
8-K
ulm8s0g430yimrkwjl8
9 Nov 18
Wave Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business Update
7:47am
8-K
nrbapkpgim cd
9 Oct 18
Regulation FD Disclosure
7:55am
8-K
a2pdo1y cie15inx
3 Oct 18
Regulation FD Disclosure
4:40pm
8-K
34z su4imqouhqb
2 Oct 18
Regulation FD Disclosure
7:48am
8-K
pg2ubk0mhypnfyc 3sa7
11 Sep 18
Regulation FD Disclosure
12:00am
8-K
12ljoowcvw
13 Aug 18
Submission of Matters to a Vote of Security Holders
4:57pm
8-K
izyw50smxivy9f
9 Aug 18
Wave Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update
8:10am
8-K
itartp8j9dl16d
9 May 18
Wave Life Sciences Reports First Quarter 2018 Financial Results and Provides Business Update
8:07am
8-K
17rlgs1 e6m
10 Apr 18
Regulation FD Disclosure
12:00am
8-K
qyl1gs5j3h
2 Apr 18
Entry into a Material Definitive Agreement
12:00am
8-K
dakwq4we8q5lox34c
26 Mar 18
Regulation FD Disclosure
12:00am
8-K
h100as6b
12 Mar 18
Wave Life Sciences Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Business Update
12:00am
8-K
w80spgb6y5wwkljsyam2
20 Feb 18
Wave Life Sciences and Takeda Form Global Strategic Collaboration to Advance Therapies for Central Nervous System Disorders
12:00am
8-K
oc3rof7dg0gf40oeq5
5 Jan 18
Regulation FD Disclosure
12:00am
8-K
ftn4stjurmbwenwiyv0q
11 Dec 17
Regulation FD Disclosure
12:00am